From July 1, 2022 to September 30, 2022, the company has repurchased 2,009,243 shares, representing 0.58% for CNY 48.71 million. With this, the company has completed the repurchase of 2,009,243 shares, representing 0.58% for CNY 48.71 million under the buyback announced on June 30, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18.64 CNY | +0.11% | -3.67% | -14.14% |
05-31 | Zhejiang Tianyu Pharmaceutical Co., Ltd. Announces Dividend Implementation for 2023, Payable on 06 June 2024 | CI |
05-06 | China Approves Tianyu Pharma's Heart Medication | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.14% | 884M | |
+19.64% | 42.33B | |
+21.25% | 22.47B | |
+18.92% | 15.25B | |
+53.19% | 12.6B | |
-0.05% | 6.79B | |
-11.11% | 6.71B | |
-8.87% | 5.73B | |
+14.68% | 5.47B | |
+6.91% | 4.78B |
- Stock Market
- Equities
- 300702 Stock
- News Zhejiang Tianyu Pharmaceutical Co., Ltd.
- Tranche Update on Zhejiang Tianyu Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 30, 2022.